| Target Price | kr173.40 |
| Price | kr151.10 |
| Potential |
14.76%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Vitrolife 2026 .
The average Vitrolife target price is kr173.40.
This is
14.76%
register free of charge
kr241.50
59.83%
register free of charge
kr154.53
2.27%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Vitrolife to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vitrolife stock has an average upside potential 2026 of
14.76%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 3.61 | 3.56 |
| 2.76% | 1.39% | |
| EBITDA Margin | 29.26% | 30.43% |
| 5.18% | 4.00% | |
| Net Margin | 14.21% | 12.31% |
| 112.96% | 13.40% |
7 Analysts have issued a sales forecast Vitrolife 2025 . The average Vitrolife sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Vitrolife EBITDA forecast 2025. The average Vitrolife EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Vitrolife Analysts have issued a net profit forecast 2025. The average Vitrolife net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 3.79 | 3.24 |
| 113.33% | 14.51% | |
| P/E | 46.69 | |
| EV/Sales | 5.93 |
7 Analysts have issued a Vitrolife forecast for earnings per share. The average Vitrolife EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 21 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 02 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 21 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 02 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Apr 24 2025 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Apr 23 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Mar 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


